• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

角膜和结膜病原体对环丙沙星的敏感性。

Susceptibility of corneal and conjunctival pathogens to ciprofloxacin.

作者信息

Knauf H P, Silvany R, Southern P M, Risser R C, Wilson S E

机构信息

Departments of Ophthalmology, University of Texas Southwestern Medical Center at Dallas, USA.

出版信息

Cornea. 1996 Jan;15(1):66-71.

PMID:8907383
Abstract

Ciprofloxacin 0.3% ophthalmic solution has been shown to be effective in the treatment of bacterial keratitis and conjunctivitis, and many physicians use ciprofloxacin as sole therapy in these conditions. In this retrospective study, we found seven of 84 isolates from corneal and conjunctival cultures that were resistant to ciprofloxacin. All of the resistant organisms were gram positive. Six of the isolates (Staphylococcus aureus, Staphylococcus hominis, and four isolates of the Streptococcus viridans group) were from corneal cultures, and one (Staphylococcus aureus) was from a conjunctival culture. Yearly records of systemic isolates from 1988 to 1993 (n = 35,308) demonstrated a statistically significant decrease in susceptibility for several organisms that are common pathogens in the conjunctiva and cornea: Pseudomonas aeruginosa (95-90%, p = 0.001); Staphylococcus aureus (96-87%, p < 0.0001); Staphylococcus spp., coagulase negative (97-81%, p < 0.0001); Enterococcus spp. (92-79%, p < 0.0001); Acinetobacter anitratus (97-77%, p = 0.0006); and Enterobacter cloacae (100-96%, p = 0.03). Although the susceptibility of corneal and conjunctival isolates in this series remained relatively high (91.7%), a much larger series of systemic isolates that are common ocular pathogens revealed a statistically significant increase in resistance to ciprofloxacin over the preceding 5 years.

摘要

0.3%环丙沙星滴眼液已被证明对细菌性角膜炎和结膜炎的治疗有效,许多医生在这些病症中将环丙沙星作为唯一治疗药物。在这项回顾性研究中,我们从角膜和结膜培养物的84株分离菌中发现7株对环丙沙星耐药。所有耐药菌均为革兰氏阳性菌。其中6株分离菌(金黄色葡萄球菌、人葡萄球菌和4株草绿色链球菌)来自角膜培养物,1株(金黄色葡萄球菌)来自结膜培养物。1988年至1993年(n = 35308)全身分离菌的年度记录显示,几种常见于结膜和角膜的病原体对环丙沙星的敏感性出现了具有统计学意义的下降:铜绿假单胞菌(95% - 90%,p = 0.001);金黄色葡萄球菌(96% - 87%,p < 0.0001);凝固酶阴性葡萄球菌属(97% - 81%,p < 0.0001);肠球菌属(92% - 79%,p < 0.0001);鲍曼不动杆菌(97% - 77%,p = 0.0006);阴沟肠杆菌(100% - 96%,p = 0.03)。尽管该系列中角膜和结膜分离菌的敏感性仍相对较高(91.7%),但一系列数量更多的常见眼部病原体全身分离菌显示,在过去5年中对环丙沙星的耐药性出现了具有统计学意义的增加。

相似文献

1
Susceptibility of corneal and conjunctival pathogens to ciprofloxacin.角膜和结膜病原体对环丙沙星的敏感性。
Cornea. 1996 Jan;15(1):66-71.
2
Comparison of ciprofloxacin and ofloxacin using human corneal susceptibility levels.使用人角膜药敏水平对环丙沙星和氧氟沙星进行比较。
Cornea. 1998 May;17(3):282-7.
3
Update on bacterial conjunctivitis in South Florida.南佛罗里达州细菌性结膜炎的最新情况
Ophthalmology. 2008 Jan;115(1):51-6. doi: 10.1016/j.ophtha.2007.03.076. Epub 2007 Jun 18.
4
In vitro ciprofloxacin resistance patterns of gram-positive bacteria isolated from clinical specimens in a teaching hospital in Saudi Arabia.沙特阿拉伯一家教学医院临床标本中分离出的革兰氏阳性菌的体外环丙沙星耐药模式。
J Ayub Med Coll Abbottabad. 2009 Jul-Sep;21(3):54-6.
5
Ciprofloxacin and levofloxacin resistance among methicillin-sensitive Staphylococcus aureus isolates from keratitis and conjunctivitis.来自角膜炎和结膜炎的甲氧西林敏感金黄色葡萄球菌分离株对环丙沙星和左氧氟沙星的耐药性
Am J Ophthalmol. 2004 Mar;137(3):453-8. doi: 10.1016/j.ajo.2003.10.026.
6
Shifting trends in bacterial keratitis in Toronto: an 11-year review.多伦多细菌性角膜炎的变迁趋势:一项 11 年回顾。
Ophthalmology. 2012 Sep;119(9):1785-90. doi: 10.1016/j.ophtha.2012.03.031. Epub 2012 May 23.
7
Frequency of isolation and antimicrobial susceptibility of bacteria isolated from bloodstream infections at Children's Medical Center, Tehran, Iran, 1996-2000.1996 - 2000年伊朗德黑兰儿童医学中心血流感染分离细菌的分离频率及抗菌药敏情况
Int J Antimicrob Agents. 2005 Nov;26(5):373-9. doi: 10.1016/j.ijantimicag.2005.08.004. Epub 2005 Oct 4.
8
Clinical resistance of Staphylococcus keratitis to ciprofloxacin monotherapy.角膜葡萄球菌对环丙沙星单一疗法的临床耐药性。
Indian J Ophthalmol. 2004 Dec;52(4):287-92.
9
In vitro susceptibility of bacterial keratitis pathogens to ciprofloxacin. Emerging resistance.细菌性角膜炎病原体对环丙沙星的体外敏感性。新出现的耐药性。
Ophthalmology. 1999 Jan;106(1):80-5. doi: 10.1016/S0161-6420(99)90008-8.
10
Emerging fluoroquinolone resistance in bacterial keratitis: a 5-year review.细菌性角膜炎中氟喹诺酮耐药性的新出现:一项5年回顾
Ophthalmology. 1999 Jul;106(7):1313-8.

引用本文的文献

1
Clinical Features and Molecular Characteristics of Methicillin-Susceptible Ocular Infection in Taiwan.台湾地区甲氧西林敏感眼部感染的临床特征与分子特征
Antibiotics (Basel). 2021 Nov 25;10(12):1445. doi: 10.3390/antibiotics10121445.
2
Bacterial Keratitis: Isolated Organisms and Antibiotic Resistance Patterns in San Francisco.细菌性角膜炎:旧金山的分离菌株及抗生素耐药模式
Cornea. 2018 Jan;37(1):84-87. doi: 10.1097/ICO.0000000000001417.
3
Esculentin-1a(1-21)NH2: a frog skin-derived peptide for microbial keratitis.Esculentin-1a(1-21)NH2:一种源自蛙皮的肽,用于治疗微生物性角膜炎。
Cell Mol Life Sci. 2015 Feb;72(3):617-627. doi: 10.1007/s00018-014-1694-0. Epub 2014 Aug 3.
4
Novel antibiotic regime for pseudomonal scleritis complicating scleral buckling surgery.治疗巩膜扣带术后并发铜绿假单胞菌性巩膜炎的新型抗生素方案。
BMJ Case Rep. 2010 Apr 29;2010:bcr01.2009.1514. doi: 10.1136/bcr.01.2009.1514.
5
Medical management approach to infectious keratitis.感染性角膜炎的医学管理方法。
Indian J Ophthalmol. 2008 May-Jun;56(3):215-20. doi: 10.4103/0301-4738.40360.
6
The use of antimicrobial peptides in ophthalmology: an experimental study in corneal preservation and the management of bacterial keratitis.抗菌肽在眼科的应用:角膜保存及细菌性角膜炎治疗的实验研究
Trans Am Ophthalmol Soc. 2002;100:243-71.
7
In vitro antibiotic resistance in bacterial keratitis in London.伦敦细菌性角膜炎的体外抗生素耐药性
Br J Ophthalmol. 2000 Jul;84(7):687-91. doi: 10.1136/bjo.84.7.687.
8
Fluoroquinolone and fortified antibiotics for treating bacterial corneal ulcers.用于治疗细菌性角膜溃疡的氟喹诺酮类和强化抗生素。
Br J Ophthalmol. 2000 Apr;84(4):378-84. doi: 10.1136/bjo.84.4.378.
9
The use of eardrops in an ENT department.耳鼻喉科中耳滴剂的使用。
Pharm World Sci. 1999 Dec;21(6):266-9. doi: 10.1023/a:1008712422891.